Insider Transactions in Q2 2025 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-1.66%
|
$505,000
$101.47 P/Share
|
|
May 27
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.19%
|
$180,000
$36.05 P/Share
|
|
May 19
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-1.14%
|
$227,400
$100.84 P/Share
|
|
May 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,752
-4.84%
|
$283,456
$103.62 P/Share
|
|
May 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,752
+12.26%
|
$148,608
$54.13 P/Share
|
|
May 05
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-0.83%
|
$231,948
$102.28 P/Share
|
|
Apr 01
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,498
-0.37%
|
$214,828
$86.88 P/Share
|